| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.0041 | 1 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.00096 | 1 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.004 | 1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.00091 | 1 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.00089 | 1 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00084 | 1 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |